Dutasteride
| CAS No. | 164656-23-9 |
|---|---|
| MDL No. | MFCD00937869 |
| MF | C27H30F6N2O2 |
| MW | 528.50 |
| InChI Key | JWJOTENAMICLJG-QWBYCMEYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Dutasteride is a synthetic 4-azasteroid and aza-steroid that replaces the tert-butyl group with a 2,5-bis(trifluoromethyl)phenyl group. It is a selective inhibitor of both type 1 and type 2 steroid 5α-reductase, an enzyme that converts testosterone to 5α-dihydrotestosterone. Used to treat symptomatic benign prostatic hyperplasia in men with an enlarged prostate, it functions as an EC 1.3.1.22 [3-oxo-5α-steroid 4-dehydrogenase (NADP(+))] inhibitor and an antihyperplasia drug. It is a member of (trifluoromethyl)benzenes and delta-lactams, and derives from a hydride of a 5α-androstane.
| CAS No. | 164656-23-9 |
|---|---|
| Product Name | Dutasteride |
Biological Targets
SRD5A1·SRD5A2·SRD5A3
Associated Conditions
prostate carcinoma·aging·hypogonadism·amyotrophic lateral sclerosis·benign prostatic hyperplasia·
* The information provided here is compiled from public sources and is for reference only.
